Free Access
| Issue |
Med Sci (Paris)
Volume 28, Number 1, Janvier 2012
|
|
|---|---|---|
| Page(s) | 37 - 38 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2012281013 | |
| Published online | 27 January 2012 | |
- Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005 ; 438 : 932–936. [CrossRef] [PubMed] [Google Scholar]
- Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007 ; 6 : 273–286. [CrossRef] [PubMed] [Google Scholar]
- Le Bouteiller P, Tabiasco J, Polgar B, et al. CD160: a unique activating NK cell receptor. Immunol Lett 2011 ; 138 : 170–175. [CrossRef] [Google Scholar]
- Bensussan A. Lutte d’influence membranaire pour inhiber ou activer le lymphocyte. Med Sci (Paris) 2008 ; 24 : 361–362. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Fons P, Chabot S, Cartwright JE, et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006 ; 108 : 2608–2615. [CrossRef] [PubMed] [Google Scholar]
- Chabot S, Jabrane-Ferrat N, Bigot K, et al. A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med 2011 ; 208 : 973–986. [CrossRef] [PubMed] [Google Scholar]
- Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005 ; 307 : 58–62. [CrossRef] [PubMed] [Google Scholar]
- Le Bouteiller P, Barakonyi A, Giustiniani J, et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci USA 2002 ; 99 : 16963–16968. [CrossRef] [Google Scholar]
- Barakonyi A, Rabot M, Marie-Cardine A, et al. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J Immunol 2004 ; 173 : 5349–5354. [PubMed] [Google Scholar]
- Cao Y, Langer R. Optimizing the delivery of cancer drugs that block angiogenesis. Sci Transl Med 2010 ; 2 : 15ps13. [Google Scholar]
- Leveziel N, Soubrane G, Souied EH. Anti-VEGF : applications pratiques en ophtalmologie. Med Sci (Paris) 2009 ; 25 : 1105–1107. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.